Outpatient Reimbursement to Increase 65 Percent for EchoGo Heart Failure Platform in 2024
Reimbursement for use of the artificial intelligence (AI)-powered EchoGo Heart Failure platform in hospital outpatient settings for Medicare and Medicaid patients is expected to increase from $99.81 to $284.88 in 2024.
Use of an FDA-cleared artificial intelligence (AI)-enabled system, which reportedly facilitates earlier detection of heart failure with preserved ejection fraction (HFpEF), will generate higher outpatient reimbursement in 2024, according to newly issued coding updates from the Centers for Medicare and Medicaid Services (CMS).
In an update to the ambulatory payment classification (APC) for the Healthcare Common Procedure Coding System (HCPCS) code C9786, the CMS has increased reimbursement from $99.81 to $284.88 for use of the EchoGo Heart Failure system, according to Ultromics, the manufacturer of the platform. The increased reimbursement for the device will go into effect on January 1, 2024.
The EchoGo Heart Failure platform, which received FDA 510(k) clearance in December 2022, reportedly diagnoses HFpEF through analysis of a single echocardiogram view. An August 2023 study noted a 95 percent area under the receiver operating characteristic curve (AUC) in validation testing for HFpEF detection.
“Approximately 50 percent of non-invasive cardiac imaging tests are performed in office-based settings so there is exciting potential for this reimbursement decision to unlock new opportunity to further broaden adoption of our technology,” added Ross Upton, the CEO and founder of Ultromics.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
